Mazdutide presents a designed peptide structure that supports investigation of receptor-ligand interactions and sequence-derived conformations. Its diverse residues modulate hydrophobicity and charge distribution. Researchers study its folding behavior to evaluate stability and solubility profiles. Applications extend to peptide engineering, signaling analysis, and structural optimization.
CAT No: R2450
CAS No:2259884-03-0
Synonyms/Alias:Mazdutide;2259884-03-0;IBI362;GLXC-26803;
Mazdutide, also known as IBI362, is a novel dual agonist peptide designed to target both the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. Engineered to mimic the actions of endogenous incretin and glucagon peptides, Mazdutide exhibits a unique mechanism that influences metabolic processes through multiple pathways. Its structure allows for enhanced receptor affinity and prolonged activity, making it a valuable tool for researchers investigating metabolic regulation. With its dual receptor agonism, Mazdutide offers a sophisticated approach to modulating glucose and lipid metabolism, supporting a broad range of scientific inquiries in the fields of endocrinology and metabolic disease research. The peptide's biochemical properties facilitate in vitro and in vivo studies, enabling the exploration of complex physiological responses and mechanistic pathways associated with energy balance.
Metabolic Disease Research: Mazdutide plays a significant role in the study of metabolic disorders by providing a means to modulate both GLP-1 and glucagon signaling. Researchers utilize it to investigate how dual agonism impacts glucose homeostasis, insulin sensitivity, and lipid metabolism in cellular and animal models. Its ability to activate two key receptors allows for the dissection of pathways involved in metabolic regulation, supporting the development of new hypotheses regarding the interplay between incretin and glucagon systems.
Obesity Mechanism Studies: IBI362 is frequently employed in preclinical research focused on obesity and energy expenditure. By simultaneously stimulating GLP-1 and glucagon receptors, it enables scientists to assess the combined effects on appetite control, thermogenesis, and fat oxidation. These studies help elucidate the molecular mechanisms underlying weight regulation and energy balance, providing insights that are critical for advancing obesity research and identifying potential therapeutic targets.
Pharmacological Characterization: The dual agonist nature of Mazdutide makes it an ideal compound for pharmacological profiling and receptor signaling studies. Researchers use it to characterize the downstream signaling cascades activated by GLP-1 and glucagon receptor engagement, including cAMP production, PKA activation, and other intracellular events. This application aids in understanding receptor selectivity, potency, and efficacy, which are essential parameters for the rational design of next-generation metabolic modulators.
Peptide Engineering and Optimization: As a structurally advanced peptide, Mazdutide serves as a template for the design and optimization of novel dual or multi-agonist compounds. Scientists leverage its molecular framework to explore modifications that enhance stability, receptor selectivity, or pharmacokinetic profiles. These efforts contribute to the advancement of peptide engineering, supporting the creation of innovative molecules for research and potential translational applications.
Comparative Agonist Studies: The availability of Mazdutide enables direct comparisons with other GLP-1 or glucagon receptor agonists in experimental settings. Researchers can systematically evaluate differences in receptor activation, metabolic effects, and safety profiles, facilitating a deeper understanding of dual versus single agonist strategies. Such comparative studies are fundamental for refining research models and optimizing compound selection in metabolic research pipelines.
In summary, Mazdutide stands at the forefront of metabolic research as a versatile dual agonist peptide. Its applications span metabolic disease modeling, obesity mechanism studies, pharmacological characterization, peptide engineering, and comparative agonist research. By providing a multifaceted approach to the study of energy homeostasis and metabolic regulation, Mazdutide empowers scientists to unravel complex physiological processes and supports the ongoing development of innovative research tools in the field of endocrinology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More